Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

89.95 +0.83 (+0.93%)
Streaming Delayed Price Updated: 10:46 AM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗
Immunome develops antibody therapeutics for cancer and infectious diseases, reporting a market cap above $2 billion in the latest filing. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗
Liquidia develops inhaled and injectable therapies for pulmonary arterial hypertension, targeting unmet needs in the U.S. biopharma market. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough
United Therapeutics Corporation (Nasdaq: UTHR) has long been a favorite of biotech investors who value both steady cash flows and visionary "moonshot" projects. On February 25, 2026, the company... 
Via Finterra
Topics Earnings Economy Intellectual Property
Liquidia Corp (NASDAQ:LQDA) Identified as High-Growth Momentum Candidate by Minervini Trend Template ↗
Via Chartmill
LIQUIDIA CORP (NASDAQ:LQDA) Emerges as a High-Growth Momentum and Trend Template Candidate ↗
Via Chartmill
News headline image
United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’
As of February 26, 2026, United Therapeutics Corporation (NASDAQ: UTHR) stands at a pivotal crossroads in the biotechnology sector. Long recognized as a dominant force in the treatment of pulmonary... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
What's Next: Liquidia's Earnings Preview ↗
 
Via Benzinga
News headline image
Why Liquidia Stock Rocked the Market Today ↗
The company is clearly benefiting from the solid momentum of its newest drug on the market. 
Via The Motley Fool
News headline image
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corp (NASDAQ:LQDA) Emerges as a High-Growth Momentum Leader ↗
Liquidia Corp (LQDA) exemplifies a high-growth momentum stock in a strong technical uptrend, combining surging revenue with a top-rated chart pattern. 
Via Chartmill
News headline image
One Fund Just Dumped $13 Million in This Offshore Drilling Stock — Here's What Long-Term Investors Should Know ↗
One fund just walked away from a rising offshore driller—here’s what long-term investors should make of the move. 
Via The Motley Fool
News headline image
This Small-Cap Consumer Stock Has Landed New Institutional Backing as Shares Surge 60% ↗
A fast-growing niche segment may be the real reason this small-cap consumer products stock is drawing new institutional attention. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys ↗
One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Liquidia Corp (LQDA) Stock: A High-Growth Pick Meeting the Minervini Trend Template ↗
Liquidia (LQDA) stock shows a powerful technical uptrend and explosive 1,121% revenue growth, aligning with the high-momentum Minervini strategy. 
Via Chartmill
News headline image
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Expert Outlook: Liquidia Through The Eyes Of 7 Analysts ↗
 
Via Benzinga
News headline image
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corp (NASDAQ:LQDA) Smashes Q3 2025 Estimates with Stellar YUTREPIA Launch ↗
Liquidia's Q3 2025 results crushed expectations with $54.3M revenue, driven by the successful launch of YUTREPIA. The stock surged as the company moves toward profitability. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗
Insmed stock surged early Thursday as Argenx stock rose more moderately. The top-notch biotech companies beat third-quarter calls. 
Via Investor's Business Daily
News headline image
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
What 5 Analyst Ratings Have To Say About Liquidia ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.